XNYS · ABBV

+0.04% · +$0.1000 · Vol 6.9M

Market closed · last close 4:00 PM ET · price as of 19:00:00 ET

ABBVIE INC.

PHARMACEUTICAL PREPARATIONS

$254.49

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is ABBV moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move ABBV next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 17
Score
Score moved -3
68/BUY BIAS -> 65/BUY BIAS
Veridion score historySource
Jul 6
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 9
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jun 3
CongressChecking access
Hon. Josh Gottheimer sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
May 11
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Apr 7
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 9
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

Catalyst calendar

Dated receipts for ABBV are being assembled.

About ABBVIE INC.

PHARMACEUTICAL PREPARATIONS

Listed since

2012

Employees

57K

Country

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$257.00

Day high

$260.96

Day low

$254.29

Previous close

$254.39

52W high

$261.07

-2.52% from high

52W low

$184.85

91% of range

Market cap

$449.6B

P/E

147.10×

EPS

$1.73

Beta

-0.07

Shares out

1.8B

Volume

6.9M

0.84× rel vol

Avg volume

8.2M

VWAP

$256.31

Price history computed in-house

+2.62%

+17.55%

+24.07%

+34.47%

YTD

+11.38%

SMA 50 $228.11 · above

SMA 200 $223.50 · above

52W position 91%

Veridion warehouse edge

Warehouse intelligence for ABBV.

Veridion Score

Checking plan access.

Congress 30d

No recent disclosure on file.

Insider activity

See Form 4 panel below.

13F holders

Vanguard

Receipt-backed holder profiles

Vanguard · $41.3B BlackRock · $32.8B State Street · $17.7B

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around ABBV.Congress disclosuresOpen receipt and filing context for ABBV.MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

ABBV insider activity

ABBVIE INC.

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for ABBV.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

SEC Form 4 ledger

Receipt-backed filing rows for ABBV are being assembled from the latest scheduled snapshot.

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

ABBV contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for ABBV in this window.

Lobbying spend

ABBV lobbying filings, year to date.

Registered lobbying filings matched to ABBVIE INC..

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for ABBV in this window.

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Composite trend over time

Why is ABBV moving today?

What can move ABBV next.

Warehouse intelligence for ABBV.

Continue the ABBV research trail.

ABBV insider activity

ABBV contract awards, year to date.

ABBV lobbying filings, year to date.

Cross-references from this score page.

What can move ABBV next.

ABBV insider activity

Cross-references from this score page.